TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biozone Scientific Scandinavia AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,375
|
3,646
|
3,980 |
Financial expenses |
10
|
21
|
13 |
Earnings before taxes |
23
|
74
|
-49 |
EBITDA |
15
|
87
|
-37 |
Total assets |
727
|
1,146
|
1,472 |
Current assets |
727
|
1,146
|
1,472 |
Current liabilities |
246
|
503
|
640 |
Equity capital |
481
|
643
|
832 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
66.2%
|
56.1%
|
56.5% |
Turnover per employee |
1,688
|
1,823
|
1,990 |
Profit as a percentage of turnover |
0.7%
|
2.0%
|
-1.2% |
Return on assets (ROA) |
4.5%
|
8.3%
|
-2.4% |
Current ratio |
295.5%
|
227.8%
|
230.0% |
Return on equity (ROE) |
4.8%
|
11.5%
|
-5.9% |
Change turnover |
-289
|
-12
|
-1,178 |
Change turnover % |
-8%
|
0%
|
-23% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.